Patients Discontinuing Weight-Loss Medications Put On Pounds Far More Rapidly Compared to Dieters

New research indicates that patients who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who halt conventional lifestyle plans.

Research printed in a leading health publication demonstrates that while overweight individuals can lose a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"Individuals buying these medications must be cognizant of the risk of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.

Such speed of regain implies a return to starting weight in about a year and a half.

Weighing Therapies

The study, which reviewed 37 of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with older methods.

Scientists point out that individuals who shed pounds through dieting generally experience a more gradual weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Regain

Nutrition scientists believe the mode of action of the injections explains the amplified weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication results in hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Condition?

Health authorities recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts argue that, considering the significant potential of relapse, the therapy should be considered ongoing.

This opinion is echoed by pharmaceutical companies, who state that the results "highlight the long-term character of excess weight," comparing it to managing diseases like diabetes.

User Accounts

Users who have stopped the medication report a intense resurgence of cravings.

"It felt as if a switch activating and you become ravenous," said an individual.

The struggle is exacerbated if individuals have not developed permanent lifestyle or habit modifications during treatment.

Widespread Use

Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with demand being substantial.

• Adoption is higher among women compared to men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

In conclusion, researchers stress that while the jabs are potent tools for weight loss, they are not a standalone solution and long-term success relies on combined behavioural changes.